What steps do we need to take to improve diagnosis of tuberculosis in children?

References

• World Health Organization. Epidemiology of childhood TB. Available from: http://www.who.int/tb/challenges/ChildhhoodTB_section1.pdf?ua=1
   Google Scholar
• European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe, 2014. 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/tuberculosis-surveillance-monitoring-Europe-2014.pdf
   Google Scholar
• American Academy of Pediatrics. [Tuberculosis] In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; Elk Grove Village, IL: 2012. p. 680-701
   Google Scholar
• National Institute for Health and Care Excellence: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institute for Health and Care Excellence, Manchester 2011. Available from: http://www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf
   Google Scholar
• World Health Organization: Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. World Health Organization, Geneva 2011. Available at http://whqlibdoc.who.int/publications/2011/9789241502672_eng.pdf
   Google Scholar
• Starke JR. Commitee on Infectious Disease. Interferon- release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014;134:1763-73
   PubMed Web of Science ®Google Scholar
• Cuevas LE, Browning R, Bossuyt P, et al. Evaluation of tuberculosis diagnostics in children. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis 2012;205:209-15
   PubMed Web of Science ®Google Scholar
• van Zyl-Smit RN, Zwerling A, Dheda K, et al. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009;4:8517
   PubMed Web of Science ®Google Scholar
• Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011;30:694-700
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011;15:1018-32
   PubMed Web of Science ®Google Scholar
• Sun L, Xiao J, Miao Q, et al. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol Med Microbiol 2011;63:165-73
   Google Scholar
• Chiappini E, Accetta G, Bonsignori F, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis. Int J Immunopathol Pharmacol 2012;25:557-64
   Google Scholar
• Sollai S, Galli L, de Martino M, et al. Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infectionin children: a 2013 update. BMC Infect Dis 2014;14:6
   PubMed Web of Science ®Google Scholar
• Schopfer K, Rieder HL, Bodmer T, et al. The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis. Eur J Pediatr 2014;173:331-6
   Google Scholar
• Lodha R, Mukherjee A, Saini D, et al. Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis. Int J Tuberc Lung Dis 2013;17:1383-8
   Google Scholar
• Mandalakas AM, Kirchner HL, Walzl G, et al. Optimizing the Detection of Recent Tuberculosis Infection in Children in a High TB-HIV Burden Setting. Am J Respir Crit Care Med 2015;191(7):820-30
   Google Scholar
• Chiappini E, Bonsignori F, Mazzantini R, et al. Interferon-gamma release assay sensitivity in children younger than 5 years is insufficient to replace the use of tuberculin skin test in western countries. Pediatr Infect Dis J 2014;33:1291-3
   PubMed Web of Science ®Google Scholar
• Lagrange PH, Thangaraj SK, Dayal R, et al. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One 2013;8:73579
   Google Scholar
• Garazzino S, Galli L, Chiappini E, et al. Performance of interferon-γ release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: a multicenter study of the Italian Society of Pediatric Infectious Diseases. Pediatr Infect Dis J 2014;33:226-31
   Web of Science ®Google Scholar
• Mukherjee A, Saini S, Kabra SK, et al. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis. Eur J Clin Nutr 2014;68:38-42
   PubMed Web of Science ®Google Scholar
• Oberhelman RA, Soto-Castellares G, Gilman RH. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis 2010;10:612-20
   PubMed Web of Science ®Google Scholar
• Ruiz Jiménez M, Guillén Martín S, Prieto Tato LM, et al. Induced sputum versus gastric lavage for the diagnosis of pulmonary tuberculosis in children. BMC Infect Dis 2013;13:222
   PubMed Web of Science ®Google Scholar
• Thomas TA, Heysell SK, Moodley P, et al. Intensified specimen collection to improve tuberculosis diagnosis in children from Rural South Africa, an observational study. BMC Infect Dis 2014;14:11
   Google Scholar
• Planting NS, Visser GL, Nicol MP, et al. Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2014;18:8-12
   Google Scholar
• Mukherjee A, Singh S, Lodha R, et al. Delhi Pediatric TB Study Group. Ambulatory gastric lavages provide better yields of Mycobacterium tuberculosis than induced sputum in children with intrathoracic tuberculosis. Pediatr Infect Dis J 2013;32:1313-17
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Singh S, Lodha R, et al. Ambulatory gastric lavages provide better yields of Mycobacterium tuberculosis than induced sputum in children with intrathoracic tuberculosis. Pediatr Infect Dis J 2013;32:1313-17
   PubMed Web of Science ®Google Scholar
• Hatherill M, Hawkridge T, Zar HJ, et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child 2009;94:195-201
   PubMedGoogle Scholar
• Marais BJ, Brittle W, Painczyk K, et al. Use of light-emitting diode fluorescence microscopi to detect acid-fast bacilli in sputum. Clin Infect Dis 2008;47:203-7
   PubMedGoogle Scholar
• Parashar D, Kabra SK, Lodha R, et al. Does neutralization of gastric aspirates from children with suspected intrathoracic tuberculosis affect mycobacterial yields on MGIT culture? J Clin Microbiol 2013;51:1753-6
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention: Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. MMWR 2009;58:7-10
   PubMedGoogle Scholar
• Lima JF, Montenegro LM, Montenegro RA, et al. Performance of nested PCR in the specific detection of Mycobacterium tuberculosis complex in blood samples of pediatric patients. J Bras Pneumol 2009;35:690-7
   Google Scholar
• Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010;35:1346-53
   PubMed Web of Science ®Google Scholar
• Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One 2010;5:10508
   Google Scholar
• Dosanjh DP, Bakir M, Millington KA, et al. Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLoS One 2011;6:28754
   Google Scholar
• Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 2012;12:175-87
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, et al. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007;9:806-12
   PubMed Web of Science ®Google Scholar
• Yassin MA, Petrucci R, Garie KT, et al. Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One 2011;6:23733
   Web of Science ®Google Scholar
• Lighter J, Rigaud M, Huie M, et al. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 2009;13:731-6
   PubMed Web of Science ®Google Scholar
• Petrucci R, Abu Amer N, Gurgel RQ, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 2008;27:1073-7
   PubMedGoogle Scholar
• Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008;3:2858
   PubMed Web of Science ®Google Scholar
• Alsleben N, Ruhwald M, Rüssmann H, et al. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis 2012;44:256-62
   PubMed Web of Science ®Google Scholar
• Holm LL, Rose MV, Kimaro G, et al. A Comparison of Interferon-γ and IP-10 for the Diagnosis of Tuberculosis. Pediatrics 2014;134:1568-75
   Google Scholar
• Latorre I, Díaz J, Mialdea I, et al. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children. J Infect 2014;69:590-9
   PubMed Web of Science ®Google Scholar
• Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One 2008;3:3901
   PubMed Web of Science ®Google Scholar
• Yassin MA, Petrucci R, Garie KT, et al. Use of tuberculin skin test, IFN-γ release assays and IFN-γ-induced protein-10 to identify children with TB infection. Eur Respir J 2013;41:644-8
   Google Scholar
• Syed Ahamed Kabeer B, Paramasivam P, Raja A. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection. J Infect 2012;64:573-9
   Google Scholar
• Wang S, Diao N, Lu C, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One 2012;7:51338
   PubMed Web of Science ®Google Scholar
• Wergeland I, Pullar N, Assmus J, et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect 2015;70(4):381-91
   Google Scholar
• Jeong YH, Hur YG, Lee H, et al. Discrimination between active and latent tuberculosis based on the ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol 2015;53:504-10
   PubMed Web of Science ®Google Scholar
• Jain V, Armah HB, Tongren JE, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 2008;7:83
   PubMed Web of Science ®Google Scholar
• Chegou NN, Detjen AK, Thiart L, et al. Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One 2013;8:64226
   Web of Science ®Google Scholar
• Kellar KL, Gehrke J, Weis SE, et al. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One 2011;6:26545
   Google Scholar
• Frahm M, Goswami ND, Owzar K, et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 2011;91:250-6
   PubMed Web of Science ®Google Scholar
• Lighter-Fisher J, Peng CH, Tse DB. Cytokine responses to QuantiFERON® peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int J Tuberc Lung Dis 2010;14:1548-55
   PubMed Web of Science ®Google Scholar
• Phalane KG, Kriel M, Loxton AG, et al. Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis. Mediators Inflamm 2013;2013:981984
   Google Scholar
• Chiappini E, Della Bella C, Bonsignori F, et al. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One 2012;7:46041
   PubMed Web of Science ®Google Scholar
• Jiang J, Wang X, Wang X, et al. Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis. J Clin Immunol 2010;30:566-73
   Google Scholar
• Nikitina IY, Kondratuk NA, Kosmiadi GA, et al. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans. PLoS One 2012;7:43733
   Google Scholar
• Geldmacher C, Ngwenyama N, Schuetz A, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010;207:2869-81
   PubMed Web of Science ®Google Scholar
• Schuetz A, Haule A, Reither K, et al. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One 2011;6:27284
   Google Scholar
• Portevin D, Moukambi F, Clowes P, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 2014;14:931-8
   PubMed Web of Science ®Google Scholar
• Tran ST, Renschler JP, Le HT, et al. Diagnostic accuracy of microscopic Observation Drug Susceptibility (MODS) assay for pediatric tuberculosis in Hanoi, Vietnam. PLoS One 2013;8:72100
   Google Scholar
• Ha DT, Lan NT, Wolbers M, et al. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One 2009;4:8341
   PubMedGoogle Scholar
• Nhu NT, Ha DT, Anh ND, et al. Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis. BMC Infect Dis 2013;13:31
   PubMed Web of Science ®Google Scholar
• Kaforou M, Wright VJ, Levin M. Host RNA signatures for diagnostics: An example from paediatric tuberculosis in Africa. J Infect 2014;69:28-31
   Google Scholar
• Verhagen LM, Zomer A, Maes M, et al. A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children. BMC Genomics 2013;14:74
   Google Scholar
• Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014;370:1712-23
   PubMed Web of Science ®Google Scholar
• World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extra- pulmonary TB in adults and children. Policy update, 2013. Available from: http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf
   Google Scholar
• Bates M, O’Grady J, Maeurer M, et al. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis 2013;13:36-42
   PubMed Web of Science ®Google Scholar
• Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012;64:580-8
   PubMed Web of Science ®Google Scholar
• Chisti MJ, Graham SM, Duke T, et al. A prospective study of the prevalence of tuberculosis and bacteraemia in Bangladeshi children with severe malnutrition and pneumonia including an evaluation of Xpert MTB/RIF assay. PLoS One 2014;9:93776
   PubMed Web of Science ®Google Scholar
• LaCourse SM, Chester FM, Preidis G, et al. Use of Xpert for the diagnosis of pulmonary tuberculosis in severely malnourished hospitalized Malawian children. Pediatr Infect Dis J 2014;33:1200-2
   Google Scholar
• Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442-7
   PubMed Web of Science ®Google Scholar
• Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011;11:819-24
   PubMed Web of Science ®Google Scholar
• Nicol MP, Spiers K, Workman L, et al. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 2013;57:18-21
   PubMed Web of Science ®Google Scholar
• Pang Y, Wang Y, Zhao S, et al. Evaluation of the Xpert MTB/RIF assay in gastric lavage aspirates for diagnosis of smear-negative childhood pulmonary tuberculosis. Pediatr Infect Dis J 2014;33:1047-51
   Google Scholar
• Rachow A, Clowes P, Saathoff E, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012;54:1388-96
   PubMed Web of Science ®Google Scholar
• Raizada N, Sachdeva KS, Nair SA, et al. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One 2014;9:105346
   Google Scholar
• Reither DK, Manyama C, Clowes P, et al. XpertMTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. J Infect 2015;70(4):392-9
   Google Scholar
• Sekadde MP, Wobudeya E, Joloba ML, et al. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis 2013;13:133
   PubMed Web of Science ®Google Scholar
• Taylor N, Gaur RL, Baron EJ, et al. Can a simple flotation method lower the limit of detection of Mycobacterium tuberculosis in extrapulmonary samples analyzed by the GeneXpert MTB/RIF assay? J Clin Microbiol 2012;50:2272-6
   Google Scholar
• Walters E, Goussard P, Bosch C, et al. GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: A pilot study. Pediatr Pulmonol 2014;49:1133-7
   PubMed Web of Science ®Google Scholar
• Yin QQ, Jiao WW, Han R, et al. Rapid diagnosis of childhood pulmonary tuberculosis by Xpert MTB/RIF assay using bronchoalveolar lavage fluid. Biomed Res Int 2014;2014:310194
   Google Scholar
• Zar HJ, Workman L, Isaacs W, et al. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study. Lancet Glob Health 2013;1:97-104
   PubMed Web of Science ®Google Scholar
• Zar HJ, Workman L, Isaacs W, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012;55:1088-95
   PubMed Web of Science ®Google Scholar
• Reither K, Manyama C, Clowes P, et al. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: A prospective, multi-centre evaluation. J Infect 2015;70:392-9
   Google Scholar
• Detjen AK, DiNardo AR, Leyden J, et al. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med 2015. [Epub ahead of print]
   Google Scholar
• Walters E, Gie RP, Hesseling AC, et al. Rapid diagnosis of pediatric intrathoracic tuberculosis from stool samples using the Xpert MTB/RIF Assay: a pilot study. Pediatr Infect Dis J 2012;31:1316
   Google Scholar
• Maurya AK, Umrao J, Singh AK, et al. Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India. Indian J Pathol Microbiol 2013;56:139-43
   Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008;32:1165-74
   PubMed Web of Science ®Google Scholar
• Barnard M, Gey van Pittius NC, van Helden PD, et al. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol 2012;50:3712-16
   PubMed Web of Science ®Google Scholar
• Solomons RS, Visser DH, Friedrich SO, et al. Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test. Int J Tuberc Lung Dis 2015;19:74-80
   PubMed Web of Science ®Google Scholar
• A service of the U.S. National Institutes of Health. Available from: https://clinicaltrials.gov/
   Google Scholar
• World Health Organization. WHO monitoring of Xpert MTB/RIF roll-out. Available from: http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html [Accessed on 28 March 2015]
   Google Scholar